HI-Bio’s $95 Million Series B Financing Round

Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Miro’s Acquisition of Freehand

Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Renesas Electronics Corporation’s $249 Million Acquisition of Sequans Communications

Goodwin advised Renesas Electronics Corporation, and Orrick advised Sequans. Renesas Electronics Corporation (TSE: 6723) and Sequans Communications S.A. (NYSE: SQNS) announced that the two companies have entered...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here